GB202210430D0 - New treatment - Google Patents

New treatment

Info

Publication number
GB202210430D0
GB202210430D0 GBGB2210430.1A GB202210430A GB202210430D0 GB 202210430 D0 GB202210430 D0 GB 202210430D0 GB 202210430 A GB202210430 A GB 202210430A GB 202210430 D0 GB202210430 D0 GB 202210430D0
Authority
GB
United Kingdom
Prior art keywords
new treatment
treatment
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2210430.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Calliditas Therapeutics AB
Original Assignee
Calliditas Therapeutics AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Calliditas Therapeutics AB filed Critical Calliditas Therapeutics AB
Priority to GBGB2210430.1A priority Critical patent/GB202210430D0/en
Publication of GB202210430D0 publication Critical patent/GB202210430D0/en
Priority to US18/352,811 priority patent/US20240033225A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
GBGB2210430.1A 2022-01-24 2022-07-15 New treatment Ceased GB202210430D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2210430.1A GB202210430D0 (en) 2022-07-15 2022-07-15 New treatment
US18/352,811 US20240033225A1 (en) 2022-01-24 2023-07-14 Pharmaceutical compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2210430.1A GB202210430D0 (en) 2022-07-15 2022-07-15 New treatment

Publications (1)

Publication Number Publication Date
GB202210430D0 true GB202210430D0 (en) 2022-08-31

Family

ID=84540078

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2210430.1A Ceased GB202210430D0 (en) 2022-01-24 2022-07-15 New treatment

Country Status (1)

Country Link
GB (1) GB202210430D0 (en)

Similar Documents

Publication Publication Date Title
GB202016058D0 (en) Therapeautic treatment
GB202003722D0 (en) Treatment
GB202002711D0 (en) Treatment
GB202304716D0 (en) New treatment
GB202210430D0 (en) New treatment
GB202206219D0 (en) New treatment
GB202319954D0 (en) Treatment
GB202319658D0 (en) Treatment
GB202319443D0 (en) Treatment
GB202318845D0 (en) Treatment
GB202311007D0 (en) Treatment
GB202304853D0 (en) Treatment
GB202218460D0 (en) Treatment
GB202214206D0 (en) Treatment
GB202212125D0 (en) Treatment
GB202204288D0 (en) Treatment
GB202204070D0 (en) Treatment
GB202201069D0 (en) Treatment
GB202108300D0 (en) New treatment
GB202108302D0 (en) New treatment
GB202006236D0 (en) New treatment
GB202208508D0 (en) Novel treatment
GB202212566D0 (en) Combination treatment
GB202103957D0 (en) Treatment
GB202103122D0 (en) Treatment

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)